Role of p38 MAPK in CYP2E1-dependent Arachidonic Acid Toxicity
Open Access
- 1 January 2003
- journal article
- Published by Elsevier
- Vol. 278 (2) , 1115-1124
- https://doi.org/10.1074/jbc.m207856200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Cyclosporine a protects against arachidonic acid toxicity in rat hepatocytes: Role of CYP2E1 and mitochondriaHepatology, 2002
- α2B-Adrenergic Receptor Activates MAPK via a Pathway Involving Arachidonic Acid Metabolism, Matrix Metalloproteinases, and Epidermal Growth Factor Receptor TransactivationJournal of Biological Chemistry, 2002
- Of mice and men: A small animal model of hepatitis C virus replicationHepatology, 2002
- Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cellsKidney International, 2001
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Role of Cytochrome P–450 2E1 in Ethanol–, Carbon Tetrachloride— and Iron–Dependent Microsomal Lipid PeroxidationHepatology, 1992